GPX3 and squamous cell lung carcinoma: Moreover, GPX3 emerges as a promising prognostic marker and therapeutic target for both LUAD and lung squamous cell carcinoma (LUSC) (Zhang et al., 2025b; Chełchowska et al., 2025).